1. |
Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg, 2005, 3(2): 129-140.
|
2. |
Wan S, DeSmet JM, Barvais L, et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1996, 112(3): 806-811.
|
3. |
Hoffman JW Jr, Gilbert TB, Poston RS, et al. Myocardial reperfusion injury: etiology, mechanisms, and therapies. J Extra Corpor Technol, 2004, 36(4): 391-411.
|
4. |
Warren O, Alexiou C, Massey R, et al. The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg, 2007, 31(4): 665-676.
|
5. |
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration. 2011. Available at: www.cochrane-handbook.org.
|
6. |
Browning PG, Pullan M, Jackson M, et al. Leucocyte-depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery. Perfusion, 1999, 14(5): 371-377.
|
7. |
Hayashi Y, Sawa Y, Fukuyama N, et al. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in associationwith myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aorticcrossclamping for more than 120 minutes. J Thorac Cardiovasc Surg, 2003, 126(6): 1813-1821.
|
8. |
Hiramatsu Y, Koishizawa T, Matsuzaki K, et al. Leukocyte-depleted blood cardioplegia reduces cardiac troponin T release in patients undergoing coronary arterybypass grafting. Jpn J Thorac Cardiovasc Surg, 2000, 48(10): 625-631.
|
9. |
Ichihara T, Yasuura K, Maseki T, et al. The effects of using a leukocyte removal filter during cold blood cardioplegia. Surg Today, 1994, 24(11): 966-972.
|
10. |
Onorati F, Santini F, Menon T, et al. Leukocyte filtration of blood cardioplegia attenuates myocardial damage and inflammation. Eur J Cardiothorac Surg, 2013, 43(1): 81-89.
|
11. |
Ozkara C, Guler N, Kutay V, et al. Leucocyte-depleted blood cardioplegia. J Int Med Res, 2007, 35(2): 188-200.
|
12. |
Pala MG, Paolini G, Paroni R, et al. Myocardial protection with and without leukocyte depletion: a comparative study on the oxidative stress. Eur J Cardiothorac Surg, 1995, 9(12): 701-706.
|
13. |
Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg, 2004, 77(3): 956-961.
|
14. |
Roth M, Kraus B, Scheffold T, et al. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: arandomized, double-blind study. J Thorac Cardiovasc Surg, 2000, 120(4): 642-650.
|
15. |
Rubino AS, Serraino GF, Mariscalco G, et al. Leukocyte depletion during extracorporeal circulation allows better organ protection but does not changehospital outcomes. Ann Thorac Surg, 2011, 91(2): 534-540.
|
16. |
Samankatiwat P, Samartzis I, Lertsithichai P, et al. Leucocyte depletion in cardiopulmonary bypass: a comparison of four strategies. Perfusion, 2003, 18(2): 95-105.
|
17. |
Sawa Y, Taniguchi K, Kadoba K, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation, 1996, 93(9): 1640-1646.
|
18. |
Suzuki I, Ogoshi N, Chiba M, et al. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion, 1998, 13(3): 205-210.
|
19. |
De Vecchi E, Paroni R, Pala MG, et al. Role of leucocytes in free radical production during myocardial revascularisation. Heart, 1997, 77(5): 449-455.
|
20. |
Zahler S, Massoudy P, Hartl H, et al. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res, 1999, 41(3): 722-730.
|
21. |
Matheis G, Scholz M, Simon A, et al. Timing of leukocyte filtration during cardiopulmonary bypass. Perfusion, 2001, 16 Suppl: 31-37.
|
22. |
Fabbri A, Manfredi J, Piccin C, et al. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion, 2001, 16 Suppl: 11-18.
|
23. |
Munsch C. Blood cardioplegia. Perfusion, 1991, 6(4): 245-252.
|
24. |
Martin J, Krause M, Benk C, et al. Blood cardioplegia filtration. Perfusion, 2003, 18 Suppl1: 75-80.
|
25. |
Blacher C, Neumann J, Jung LA, et al. Off-pump coronary artery bypass grafting does not reduce lymphocyte activation. Int J Cardiol, 2005, 101(3): 473-479.
|